Halozyme Therapeutics, Inc. (HALO) by event type
HALO moves most on analyst downgrades — a median of -0.44% at 30 minutes across 27 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the HALO overview →
How HALO reacts across 4 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 970 of 2,717 | 19 | +0.13% | 53% | -1.22% |
| Analyst downgrades 2,163 of 2,603 | 27 | -0.44% | 33% | -1.35% |
| Rating reiterations 2,369 of 3,522 | 123 | -0.07% | 46% | +0.07% |
| Price-target raises 1,336 of 1,790 | 34 | -0.10% | 41% | +0.07% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.
That’s how HALO usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Rating reiterations → · Price-target raises → · HALO overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Autolus Therapeutics plc - American Depositary Shares (AUTL) | 377 | -0.00% | 45% |
| Solid Biosciences Inc. (SLDB) | 375 | -0.17% | 46% |
| RITTER PHARMACEUTICALS (RTTR) | 374 | -0.61% | 37% |
| MIRAGEN THERAPEUTICS INC (MGEN) | 369 | -0.39% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.